SOURCE: Accelrys

September 18, 2008 17:47 ET

Accelrys Holds Annual Meeting of Nanotechnology Consortium to Drive Customer Efficiencies

SAN DIEGO, CA--(Marketwire - September 18, 2008) - Accelrys, Inc. (NASDAQ: ACCL), a leader in Computer Aided Nanodesign™ (CAN), announced its 5th Annual Meeting of the Nanotechnology Consortium. Scientists from leading companies and research organizations from across the world will get together in San Diego, California October 15-17, 2008, to discuss the latest software developments supporting materials and process development.

A key focus of this Consortium is on developing tools and protocols that bridge the gap between atomistic simulations and engineering applications in the area of reaction kinetics. In particular, the software toolset is being extended to provide chemical engineering parameters such as rate constants, and enable engineering and molecular approaches to connect via methods such as Kinetic Monte Carlo.

"The solutions are designed to reduce costs, improve efficiency and enable faster innovation which is what our customers are demanding in this competitive landscape," said Mark J. Emkjer, president and chief executive officer of Accelrys.

About Nanotechnology Consortium

Recognizing the challenges facing organizations who are undertaking advanced materials and nanotechnology research, Accelrys, its scientific advisors and customers joined together to form the Accelrys Nanotechnology Consortium in July 2004. The Consortium gives members the opportunity to work in collaboration with scientific thought-leaders to steer Accelrys' development of leading-edge modeling and simulation software technology. It aims to give members a competitive market advantage by providing exclusive rights to technology. Following a very successful Phase I, supported by over 30 members worldwide, Phase II is now under way. Phase II focuses on technology integration, with goals to deliver flexible software solutions that address the advanced materials and nanotechnology-based industries' need for a more engineering-oriented approach to nanotechnology, delivering Computer Aided Nanodesign (CAN). For more information about the Accelrys Nanotechnology Consortium, visit its website at

About Accelrys

Accelrys develops and commercializes scientific business intelligence software for the aggregation, mining, integration, analysis, modeling and simulation, management and interactive reporting of scientific data. Our solutions are used by biologists, chemists, materials scientists, and information technology professionals for product design as well as drug discovery and development. Our technology and services are designed to meet the needs of today's leading research and development organizations including leading commercial, government and academic organizations. Many of the largest pharmaceutical, biotechnology, chemical, energy, aerospace and consumer packaged goods companies worldwide use our solutions. Accelrys is headquartered in San Diego, California. For more information about Accelrys, visit its website at

Forward-Looking Statements

This press release contains forward-looking statements. Such statements, including statements relating to the Company's products, including the products' features and potential demand therefore, are subject to risks and uncertainties including, but not limited to, the risks that the products will not be timely or successfully completed, developed or achieve market acceptance, demand relating to these products, and other risks and uncertainties described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and any subsequent interim filings. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.